Position in ICLR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$925,700
+$351,154 QoQ
Shares Held
5,329
+2.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#207
of 422 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Sterling Capital Management LLC holds $57,450,565 across 31 Diagnostics & Research names. ICLR ranks #13 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
100,645 | $27,320,084 | |
| 2 | DHR |
Danaher Corp /De/
|
66,320 | $12,632,632 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
5,328 | $2,671,246 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,902 | $2,054,168 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
7,719 | $1,491,465 | |
| 6 | ILMN |
Illumina, Inc.
|
7,216 | $1,268,789 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,769 | $1,222,739 | |
| 8 | RVTY |
Revvity, Inc.
|
10,975 | $1,221,078 |
All Filings in ICLR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $925,700 | 5,329 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $574,546 | 5,192 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $965,219 | 5,297 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,568,650 | 14,678 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,287,170 | 22,600 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,453,077 | 19,733 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,577,549 | 21,828 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,020,293 | 20,954 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||